Adverse effects of antiretroviral therapy

被引：786

作者：

Carr, A ^{[1
]}

Cooper, DA

机构：

[1] St Vincents Hosp, HIV Immunol & Infect Dis Clin Serv Unit, Sydney, NSW 2010, Australia

[2] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia

来源：

LANCET | 2000年 / 356卷 / 9239期

关键词：

D O I：

10.1016/S0140-6736(00)02854-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Antiretroviral toxicity is an increasingly important issue in the management of HIV infected patients. With the sustained major declines in opportunistic complications, HIV infection is a more chronic disease, and so more drugs are being used in more patients for longer periods. This review focuses on the pathogenesis, clinical features, and management of the principal toxicities of the 15 licensed antiretroviral drugs, including mitochondrial toxicity, hypersensitivity, and lipodystrophy, as well as more drug-specific adverse effects and special clinical settings.

引用

页码：1423 / 1430

页数：8

共 66 条

[41] Influence of environmental temperature on incidence of indinavir-related nephrolithiasis [J].

Martínez, E ;

Leguizamón, M ;

Mallolas, J ;

Miró, JM ;

Gatell, JM .

CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) :422-425

[42] Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine [J].

Martínez, E ;

Conget, I ;

Lozano, L ;

Casamitjana, R ;

Gatell, JM .

AIDS, 1999, 13 (07) :805-810

[43] Reversal of protease inhibitor-related visceral abdominal fat accumulation with recombinant human growth hormone [J].

Mauss, S ;

Wolf, E ;

Jaeger, H .

ANNALS OF INTERNAL MEDICINE, 1999, 131 (04) :313-314

[44] HEPATIC-FAILURE AND LACTIC-ACIDOSIS DUE TO FIALURIDINE (FIAU), AN INVESTIGATIONAL NUCLEOSIDE ANALOG FOR CHRONIC HEPATITIS-B [J].

MCKENZIE, R ;

FRIED, MW ;

SALLIE, R ;

CONJEEVARAM, H ;

DIBISCEGLIE, AM ;

PARK, Y ;

SAVARESE, B ;

KLEINER, D ;

TSOKOS, M ;

LUCIANO, C ;

PRUETT, T ;

STOTKA, JL ;

STRAUS, SE ;

HOOFNAGLE, JH .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (17) :1099-1105

[45]

MILLER J, IN PRESS AIDS

[46] LACTIC-ACIDOSIS IN CRITICAL ILLNESS [J].

MIZOCK, BA ;

FALK, JL .

CRITICAL CARE MEDICINE, 1992, 20 (01) :80-93

[47]

MONTANER J, 2000, P 13 WORLDS AIDS C J

[48] Peripheral neuropathy with nucleoside antiretrovirals - Risk factors, incidence and management [J].

Moyle, GJ ;

Sadler, M .

DRUG SAFETY, 1998, 19 (06) :481-494

[49] THE TREATMENT OF MITOCHONDRIAL MYOPATHIES AND ENCEPHALOMYOPATHIES [J].

PETERSON, PL .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1995, 1271 (01) :275-280

[50]

Pollmann H, 1998, THROMB HAEMOSTASIS, V79, P1213

← 1 2 3 4 5 6 7 →